All Stories

  1. Gender differences at presentation of idiopathic pulmonary fibrosis in Sweden
  2. What patients with Idiopathic Pulmonary Fibrosis and caregivers want – Filling the currents gaps with patient reported outcomes and experience measures
  3. Patient journey and treatment patterns in adults with IPF based on health care data in Sweden from 2001 to 2015
  4. Pulmonary outcomes in adults with a history of Bronchopulmonary Dysplasia differ from patients with asthma
  5. The characterisation of interstitial lung disease multidisciplinary team meetings: a global study
  6. An Atypical Case of Idiopathic Pulmonary Fibrosis in a Patient from Africa
  7. Latent tuberculous infection among foreign-born individuals applying to shelters in the metropolitan area of Milan
  8. Delay and inequalities in the treatment of idiopathic pulmonary fibrosis: the case of two Nordic countries
  9. Best supportive care for idiopathic pulmonary fibrosis: current gaps and future directions
  10. Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case–cohort study
  11. Mutational status predicts the risk of thromboembolic events in lung adenocarcinoma
  12. Antacid therapy in idiopathic pulmonary fibrosis: more questions than answers?
  13. Lung function development after preterm birth in relation to severity of Bronchopulmonary dysplasia
  14. Humoral immune profiling of mycobacterial antigen recognition in sarcoidosis and Löfgren’s syndrome using high-content peptide microarrays
  15. Immune recognition surface construction of Mycobacterium tuberculosis epitope-specific antibody responses in tuberculosis patients identified by peptide microarrays
  16. Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group
  17. Need for combined interventions and operational research to tackle tuberculous meningitis
  18. Idiopathic pulmonary fibrosis in Sweden: report from the first year of activity of the Swedish IPF-Registry
  19. T-Cell Therapy: Options for Infectious Diseases: Table 1.
  20. Macrolides for chronic asthma
  21. Recurrent respiratory infections and unusual radiology: a woman with Kartagener's syndrome
  22. Serum reactome induced by Bordetella pertussis infection and Pertussis vaccines: qualitative differences in serum antibody recognition patterns revealed by peptide microarray analysis
  23. Extra-pulmonary tuberculosis and Xpert® MTB/RIF: all about meta-analyses?
  24. Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review
  25. No association between Birt-Hogg-Dubé syndrome skin fibrofolliculomas and the first 10 described human polyomaviruses or human papillomaviruses
  26. Autologous mesenchymal stromal cell infusion as adjunct treatment in patients with multidrug and extensively drug-resistant tuberculosis: an open-label phase 1 safety trial
  27. Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children
  28. Chronic empyema: importance of preventing complications in the management of pleural effusions
  29. Isoniazid preventive treatment: predictors of adverse events and treatment completion
  30. Linezolid to treat extensively drug-resistant TB: retrospective data are confirmed by experimental evidence: Table 1–
  31. Intra-abdominal bleeding during treprostinil infusion in a patient with pulmonary arterial hypertension
  32. Intravenous Immunoglobulin (IVIg) for Refractory and Difficult-to-treat Infections
  33. Risk factors associated with pulmonary tuberculosis
  34. Trends and challenges in tuberculosis in a medium-sized southern European setting [Notes from the field]
  35. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis
  36. "Interferon-  release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis." R. Diel, D. Goletti, G. Ferrara, G. Bothamley, D. Cirillo, B. Kampmann, C. Lange, M. Losi, R. Markova, G.B. Migliori,...
  37. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children
  38. Tuberculosis in prisons: anatomy of global neglect
  39. Screening of immigrants in the UK for latent tuberculosis
  40. Xpert MTB/RIF test for tuberculosis
  41. A Decade of Interferon-γ Release Assays: Quest for the Holy Grail to Diagnose Latent Infection withMycobacterium tuberculosis?
  42. A multicentre evaluation of the accuracy and performance of IP-10 for the diagnosis of infection with M. tuberculosis
  43. The best on infections: update from the 2010 ERS Congress
  44. Tuberculosis in prisons in sub-Saharan Africa – the need for improved health services, surveillance and control
  45. Interferon-  release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis
  46. TB or not TB: update from the ERS Respiratory Infection Assembly 10
  47. Exploring the immune response against Mycobacterium tuberculosis for a better diagnosis of the infection
  48. Performance of Tests for Latent Tuberculosis in Different Groups of Immunocompromised Patients
  49. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET
  50. A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis
  51. Mycobacterium tuberculosis Induces CCL18 Expression in Human Macrophages
  52. Fluoroquinolones: are they essential to treat multidrug-resistant tuberculosis?
  53. Using ELISpot technology to improve the diagnosis of tuberculosis infection: from the bench to the T-SPOT.TBassay
  54. Extensively Drug-Resistant Tuberculosis Is Worse than Multidrug-Resistant Tuberculosis: Different Methodology and Settings, Same Results
  55. Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases
  56. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children
  57. Clinical and operational value of the extensively drug-resistant tuberculosis definition
  58. Combination fluticasone and salmeterol vesus fixed dose combination budesonide and formoterol for chronic asthma in adults and children
  59. Extensively Drug-resistant Tuberculosis, Italy and Germany
  60. Long-term moxifloxacin in complicated tuberculosis patients with adverse reactions or resistance to first line drugs
  61. Blood tests for diagnosis of tuberculosis – Authors' reply
  62. Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study
  63. Macrolides for chronic asthma
  64. Routine Hospital Use of a New Commercial Whole Blood Interferon-γ Assay for the Diagnosis of Tuberculosis Infection
  65. Macrolides for chronic asthma
  66. Community Acquired Pneumonia in Internal Medicine: A One-Year Retrospective Study Based on Pneumonia Severity Index
  67. Macrolides in the treatment of asthma and cystic fibrosis
  68. Corticosteroids for idiopathic pulmonary fibrosis
  69. Monitoring the quality of laboratories and the prevalence of resistance to antituberculosis drugs: Italy, 1998–2000
  70. Macrolides for chronic asthma